Camson Bio Technologies Limited announced unaudited standalone earnings results for the second quarter and half year ended September 30, 2018. For the quarter, the company reported revenue from operations of INR 15.192 million as compared to INR 47.003 million a year ago. Loss before tax and exceptional items was INR 53.460 million as compared to INR 25.506 million a year ago. Loss before tax was INR 53.460 million as compared INR 25.506 million a year ago. Loss for the period was INR 56.858 million as compared to INR 25.506 million a year ago. Diluted and basic loss per share was INR 1.90 as compared to INR 0.85 a year ago. For the half year, the company reported revenue from operations of INR 28.090 million as compared to INR 159.662 million a year ago. Loss before tax and exceptional items was INR 93.776 million as compared to INR 7.298 million a year ago. Loss before tax was INR 93.776 million as compared to INR 7.298 million a year ago. Loss for the period was INR 99.478 million as compared to INR 7.298 million a year ago. Diluted and basic loss per share was INR 3.32 as compared to INR 0.24 a year ago.